Northern Arizona University   Report issue

Academic/Hospital Phase 2
Founded: Flagstaff AZ United States (1899)

Organization Overview

First Clinical Trial
2014
NCT02504554
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Northern Arizona University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6